Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2016
What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2
Gil Leurquin-Sterk, Sofie Celen, Koen Van Laere, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 1, 2012
In vivo quantification of striatal dopamine D2 receptor occupancy by JNJ-37822681 using [11C]raclopride and positron emission tomography
Erik T te Beek, Peter de Boer, Matthijs Moerland, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 3, 2014
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data
Mark E Schmidt, Ping Chiao, Gregory Klein, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 24, 2017
Dissociation of Down syndrome and Alzheimer's disease effects with imaging
Dawn C Matthews, Ana S Lukic, Randolph D Andrews, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 29, 2018
<sup>18</sup>F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446
Michel Koole, Mark E Schmidt, Anja Hijzen, et al.
Clinical and Translational Science
|
March 26, 2018
Fatty Acid Amide Hydrolase Inhibition by JNJ-42165279: A Multiple-Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers
Andrey Postnov, Mark E Schmidt, Darrel J Pemberton, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 18, 2020
The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study
Mark E Schmidt, Michael R Liebowitz, Murray B Stein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 22, 2015
Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB)
Enchi Liu, Johan Luthman, Jesse M Cedarbaum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 29, 2023
The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB)
Bruce Albala, Eline Appelmans, Ramona Burress, et al.
Neuroimage
|
February 15, 2021
Uncertainty analysis of MR-PET image registration for precision neuro-PET imaging
Pawel J Markiewicz, Julian C Matthews, John Ashburner, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2016
What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2
Gil Leurquin-Sterk, Sofie Celen, Koen Van Laere, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 1, 2012
In vivo quantification of striatal dopamine D2 receptor occupancy by JNJ-37822681 using [11C]raclopride and positron emission tomography
Erik T te Beek, Peter de Boer, Matthijs Moerland, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 3, 2014
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data
Mark E Schmidt, Ping Chiao, Gregory Klein, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 24, 2017
Dissociation of Down syndrome and Alzheimer's disease effects with imaging
Dawn C Matthews, Ana S Lukic, Randolph D Andrews, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 29, 2018
<sup>18</sup>F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446
Michel Koole, Mark E Schmidt, Anja Hijzen, et al.
Clinical and Translational Science
|
March 26, 2018
Fatty Acid Amide Hydrolase Inhibition by JNJ-42165279: A Multiple-Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers
Andrey Postnov, Mark E Schmidt, Darrel J Pemberton, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 18, 2020
The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study
Mark E Schmidt, Michael R Liebowitz, Murray B Stein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 22, 2015
Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB)
Enchi Liu, Johan Luthman, Jesse M Cedarbaum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 29, 2023
The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB)
Bruce Albala, Eline Appelmans, Ramona Burress, et al.
Neuroimage
|
February 15, 2021
Uncertainty analysis of MR-PET image registration for precision neuro-PET imaging
Pawel J Markiewicz, Julian C Matthews, John Ashburner, et al.
Page
of 7